PerkinElmer (PKI) Receives a Hold from Needham

By Carrie Williams

In a report released today, Stephen Unger from Needham maintained a Hold rating on PerkinElmer (PKIResearch Report). The company’s shares closed last Monday at $87.11.

According to, Unger is a 4-star analyst with an average return of 8.6% and a 55.9% success rate. Unger covers the Healthcare sector, focusing on stocks such as Myriad Genetics, Genomic Health, and Thermo Fisher.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for PerkinElmer with a $87.50 average price target, a 1.0% upside from current levels. In a report issued on October 31, Piper Jaffray also downgraded the stock to Hold with a $89.00 price target.

See today’s analyst top recommended stocks >>

The company has a one-year high of $103.00 and a one-year low of $71.83. Currently, PerkinElmer has an average volume of 669.9K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following two segments: Discovery & Analytical Solutions, and Diagnostics.